Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma

<div>Newly diagnosed multiple myeloma patients with renal impairment, according to international myeloma working group criteria (categorized by sex) using serum creatinine and cystatin C in different equations.</div>

Advances in Hematology

fig1

Figure 1

Figure 1: Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma 